HYCOR BIOMEDICAL INC /DE/·5

Jan 13, 7:22 PM ET

HYCOR BIOMEDICAL INC /DE/ 5

5 · HYCOR BIOMEDICAL INC /DE/ · Filed Jan 13, 2004

Insider Transaction Report

Form 5
Period: 2003-12-31
DAVOUDZADEH DAVID PHD
Vice President, R&D
Transactions
  • Exercise/Conversion

    Common Stock

    2003-12-31$3.31/sh+1,085$3,5916,752 total
  • Exercise/Conversion

    Common Stock

    2003-06-30$1.78/sh+2,571$4,5764,738 total
  • Exercise/Conversion

    Common Stock

    2003-09-30$4.22/sh+929$3,9205,667 total

Documents

1 file
  • 5
    edgar.xmlPrimary

    PRIMARY DOCUMENT